American Heart Association – 2021

Ankeet Bhatt – Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19

David Berg – High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients with HFrEF. An Analysis of Serial Assessment in the DAPA-HF Trial.

Aditya Dewanjee – Elucidating Clinical Phenotypes of Patients with Mixed Shock Admitted to Cardiac Intensive Care Units. Insights from the Critical Care Cardiology Trial.

Amanda Garfinkel – Clinical Applications of a Polygenic Risk Score to Predict Atrial Fibrillation in Patients with Cardiometabolic Disease

Baris Gencer – Clinical Safety Outcomes in Relation to Lipoprotein(a) Concentration. Insights from the FOURIER trial

Jingyi Gong – Predictive value of echocardiographic markers of diastolic dysfunction for heart failure in overweight and obese patients in CAMELLIA-TIMI 61

Nicholas Marston – ApoB-containing Lipoproteins and Risk of Myocardial Infarction. Distinguishing between Particle Concentration, Type, and Content.

Nicholas Marston – Predictive Utility of a CAD Polygenic Risk Score in Primary Prevention Based on Age and Clinical Risk

Filipe Moura – Dapagliflozin and Changes in Metabolic Syndrome in Patients with Type 2 Diabetes. A DECLARE TIMI 58 Sub-analysis.

Siddharth Patel – A Genetic Risk Score to Predict Peripheral Artery Disease and Acute Limb Ischemia in Patients With Cardiometabolic Disease

Siddharth Patel – A Targeted Proteomic Approach Identifies Novel Biomarkers Associated With Risk of Myocardial Infarction in Post-Menopausal Women

Siddharth Patel – Evaluation of the ABC Pathway for Comprehensive Management of Atrial Fibrillation in 20,933 Patients from the ENGAGE AF-TIMI 48 Trial

Siddharth Patel – Ezetimibe Consistently Reduces LDL-C with Little Interindividual Variability in 14,970 Patients Post-ACS

Marc Sabatine – PCI with Drug-Eluting Stents vs. CABG in Left Main Coronary Artery Disease. An Individual Patient Data Meta-Analysis.

%d bloggers like this: